Bacterial peptidoglycan synthesis enzyme

Bacterial peptidoglycan synthesis enzymes are a group of essential enzymes responsible for constructing the peptidoglycan layer—a mesh-like polymer that forms the main structural component of most bacterial cell walls. This layer consists primarily of alternating N-acetylglucosamine and N-acetylmuramic acid residues cross-linked by short peptides. The process involves several cytoplasmic and membrane-associated steps catalyzed by different classes of enzymes including glycosyltransferases, transglycosylases, ligases, carboxypeptidases, and especially transpeptidases known as penicillin-binding proteins. These enzymatic activities are critical for maintaining cell shape and protecting bacteria from osmotic lysis during growth and division. Because humans lack this pathway entirely—having no analogous structure—these enzymes represent prime targets for many major classes of antibiotics such as β-lactams and glycopeptides. Inhibition leads to loss of cell wall integrity and ultimately bacterial death. However, widespread use has led to significant antibiotic resistance due to mutations in these targets or acquisition/production of alternative resistant forms.

Other names

Peptidoglycan biosynthetic enzymeCell wall synthesis enzymeMurein biosynthesis enzymePG synthesis enzyme

Drugs targeting these enzymes typically act by one or more of the following mechanisms: - Inhibition of transpeptidation/cross-linking in cell wall formation by binding to active sites on penicillin-binding proteins or DD-transpeptidases - Binding to D-Ala-D-Ala termini of peptidoglycan precursors to prevent polymerization/cross-linking (glycopeptides like vancomycin)